StemSynergy Therapeutics®
"Innovative Stem Cell Research. Targeted Cancer Therapeutics."

Pipeline

Through SSTI chemistry, we have developed a series of potent modulators of the Wnt, Notch, and Shh signaling pathways that reduce tumor burden in vivo. Because of the novelty in mechanisms of action and cellular targets, these compounds represent first-in-class agents for cancer treatment.

Scientific Team

SSTI has a multidisciplinary team of scientists.

Meet the Team

Leadership

Meet the founders behind StemSynergy Therapeutics, Inc.

Founders

Science

SSTI targets cancer stem cell pathways that drive tumor growth.

Scientific Programs